A Study of MEMP1972A in the Prevention of Allergen-Induced Airway Obstruction in Patients With Mild Asthma (SOLARIO)
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This Phase II, double-blind, placebo-controlled, randomized, parallel-group study is designed
to evaluate the efficacy, safety and tolerability of MEMP1972A when administered to patients
by intravenous (IV) infusion for the treatment of allergen-induced asthma.